142 related articles for article (PubMed ID: 37194408)
21. Clinical-radiological predictive model in differential diagnosis of small (≤ 20 mm) solitary pulmonary nodules.
Zhao HC; Xu QS; Shi YB; Ma XJ
BMC Pulm Med; 2021 Sep; 21(1):281. PubMed ID: 34482833
[TBL] [Abstract][Full Text] [Related]
22. Preoperative diagnosis of malignant pulmonary nodules in lung cancer screening with a radiomics nomogram.
Liu A; Wang Z; Yang Y; Wang J; Dai X; Wang L; Lu Y; Xue F
Cancer Commun (Lond); 2020 Jan; 40(1):16-24. PubMed ID: 32125097
[TBL] [Abstract][Full Text] [Related]
23. Diagnosis of colorectal cancer based on folate receptor-positive circulating tumor cell analysis: a retrospective cohort study.
Wei ZJ; Zhou BC; Wang GX; Han WX; Li YX; Xu AM
Int J Clin Oncol; 2024 Feb; 29(2):149-158. PubMed ID: 38112831
[TBL] [Abstract][Full Text] [Related]
24. [Establishment of A Clinical Prediction Model of Solid Solitary Pulmonary Nodules].
Yu W; Ye B; Xu L; Wang Z; Le H; Wang S; Cao H; Chai Z; Chen Z; Luo Q; Zhang Y
Zhongguo Fei Ai Za Zhi; 2016 Oct; 19(10):705-710. PubMed ID: 27760603
[TBL] [Abstract][Full Text] [Related]
25. Sputum microRNA biomarkers for identifying lung cancer in indeterminate solitary pulmonary nodules.
Xing L; Su J; Guarnera MA; Zhang H; Cai L; Zhou R; Stass SA; Jiang F
Clin Cancer Res; 2015 Jan; 21(2):484-9. PubMed ID: 25593345
[TBL] [Abstract][Full Text] [Related]
26. Detection of circulating rare cells benefitted the diagnosis of malignant solitary pulmonary nodules.
Xie J; Ruan Z; Zheng J; Gong Y; Wang Y; Hu B; Cheng J; Huang Q
J Cancer Res Clin Oncol; 2022 Oct; 148(10):2681-2692. PubMed ID: 34791530
[TBL] [Abstract][Full Text] [Related]
27. Risk assessment of malignancy in solitary pulmonary nodules in lung computed tomography: a multivariable predictive model study.
Liu HY; Zhao XR; Chi M; Cheng XS; Wang ZQ; Xu ZW; Li YL; Yang R; Wu YJ; Zhang XJ
Chin Med J (Engl); 2021 Jun; 134(14):1687-1694. PubMed ID: 34397595
[TBL] [Abstract][Full Text] [Related]
28. Development and validation of a clinical prediction model to estimate the probability of malignancy in solitary pulmonary nodules in Chinese people.
Li Y; Chen KZ; Wang J
Clin Lung Cancer; 2011 Sep; 12(5):313-9. PubMed ID: 21889113
[TBL] [Abstract][Full Text] [Related]
29. Value of circulating tumor cells in the diagnosis and treatment of solitary pulmonary nodules.
Liu D; Mao Y; Ma H
Ann Transl Med; 2021 Mar; 9(6):501. PubMed ID: 33850898
[TBL] [Abstract][Full Text] [Related]
30. Correlation study between dual source CT perfusion imaging and the microvascular composition of solitary pulmonary nodules.
Wang M; Li B; Sun H; Huang T; Zhang X; Jin K; Wang F; Luo X
Lung Cancer; 2019 Apr; 130():115-120. PubMed ID: 30885331
[TBL] [Abstract][Full Text] [Related]
31. A model of malignant risk prediction for solitary pulmonary nodules on
Yu M; Wang Z; Yang G; Cheng Y
Thorac Cancer; 2020 May; 11(5):1211-1215. PubMed ID: 32162769
[TBL] [Abstract][Full Text] [Related]
32. Diagnosis of Benign and Malignant Pulmonary Ground-Glass Nodules Using Computed Tomography Radiomics Parameters.
Liang L; Zhang H; Lei H; Zhou H; Wu Y; Shen J
Technol Cancer Res Treat; 2022; 21():15330338221119748. PubMed ID: 36259167
[No Abstract] [Full Text] [Related]
33. Serum phosphatidylethanolamine levels distinguish benign from malignant solitary pulmonary nodules and represent a potential diagnostic biomarker for lung cancer.
Fahrmann JF; Grapov D; DeFelice BC; Taylor S; Kim K; Kelly K; Wikoff WR; Pass H; Rom WN; Fiehn O; Miyamoto S
Cancer Biomark; 2016 Mar; 16(4):609-17. PubMed ID: 27002763
[TBL] [Abstract][Full Text] [Related]
34. Establishment and validation of a clinical model for diagnosing solitary pulmonary nodules.
Zhou L; Zhou Z; Liu F; Sun H; Zhou B; Dai L; Zhang G
J Surg Oncol; 2022 Dec; 126(7):1316-1329. PubMed ID: 35975732
[TBL] [Abstract][Full Text] [Related]
35. Developing a multi-institutional nomogram for assessing lung cancer risk in patients with 5-30 mm pulmonary nodules: a retrospective analysis.
Jiang Y; Deng T; Huang Y; Ren B; He L; Pang M; Jiang L
PeerJ; 2023; 11():e16539. PubMed ID: 38107565
[TBL] [Abstract][Full Text] [Related]
36. Using neighborhood gray tone difference matrix texture features on dual time point PET/CT images to differentiate malignant from benign FDG-avid solitary pulmonary nodules.
Chen S; Harmon S; Perk T; Li X; Chen M; Li Y; Jeraj R
Cancer Imaging; 2019 Aug; 19(1):56. PubMed ID: 31420006
[TBL] [Abstract][Full Text] [Related]
37. Overcoming Obstacles in Pathological Diagnosis of Pulmonary Nodules through Circulating Tumor Cell Enrichment.
Yin W; Zhu J; Ma B; Jiang G; Zhu Y; He W; Yang Y; Zhang Z
Small; 2020 Jun; 16(25):e2001695. PubMed ID: 32452626
[TBL] [Abstract][Full Text] [Related]
38. Analysis of Diagnostic Value of CTC and CTDNA in Early Lung Cancer.
Hongwei Yao ; Lixin Wen ; Ziyan Li ; Chunwei Xia
Cell Mol Biol (Noisy-le-grand); 2023 Jun; 69(6):57-62. PubMed ID: 37605590
[TBL] [Abstract][Full Text] [Related]
39. Clinical Utility of Circulating Tumor Cells in the Early Detection of Lung Cancer in Patients with a Solitary Pulmonary Nodule.
Zhong M; Zhang Y; Pan Z; Wang W; Zhang Y; Weng Y; Huang H; He Y; Liu O
Technol Cancer Res Treat; 2021; 20():15330338211041465. PubMed ID: 34519585
[No Abstract] [Full Text] [Related]
40. A retrospective diagnostic test study on circulating tumor cells and artificial intelligence imaging in patients with lung adenocarcinoma.
Ma M; Xu S; Han B; He H; Ma X; Chen C
Ann Transl Med; 2022 Dec; 10(24):1339. PubMed ID: 36660706
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
